SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-072058
Filing Date
2024-06-17
Accepted
2024-06-17 08:35:53
Documents
15
Period of Report
2024-06-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417394d1_8k.htm   iXBRL 8-K 35685
2 EXHIBIT 99-1 tm2417394d1_ex99-1.htm EX-99.1 20325
6 GRAPHIC tm2417394d1_ex99-1img001.jpg GRAPHIC 14923
  Complete submission text file 0001104659-24-072058.txt   258965

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avte-20240617.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avte-20240617_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avte-20240617_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2417394d1_8k_htm.xml XML 3806
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 241047030
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)